Clinical Utility of Fluid Volume Assessment in Heart Failure Patients Using Bioimpedance Spectroscopy

Andrew J Accardi, Bradley S Matsubara, Richelle L Gaw, Anne Daleiden-Burns, James Thomas Heywood, Andrew J Accardi, Bradley S Matsubara, Richelle L Gaw, Anne Daleiden-Burns, James Thomas Heywood

Abstract

Background: Bioimpedance spectroscopy (BIS) is a non-invasive method used to measure fluid volumes. In this report, we compare BIS measurements from patients with heart failure (HF) to those from healthy adults, and describe how these point-of-care fluid volume assessments may be applied to HF management. Methods and results: Fluid volumes were measured in 64 patients with NYHA class II or III HF and 69 healthy control subjects. BIS parameters including extracellular fluid (ECF), intracellular fluid (ICF), total body water (TBW), and ECF as a percentage of TBW (ECF%TBW) were analyzed. ECF%TBW values for the HF and control populations differed significantly (49.2 ± 3.2% vs. 45.2 ± 2.1%, respectively; p < 0.001); both distributions satisfied criteria for normality. Interquartile ranges did not overlap (46.7-51.0% vs. 43.8-46.4%, respectively; p < 0.001). Subgroup analyses of HF patients who underwent transthoracic echocardiography showed that impedance measurements correlated with inferior vena cava size (Pearson correlation -0.73, p < 0.0001). A case study is presented for illustrative purposes. Conclusions: BIS-measured ECF%TBW values were significantly higher in HF patients as compared to adults without HF. We describe three strata of ECF%TBW (normal, elevated, fluid overload) that may aid in clinical risk stratification and fluid volume monitoring of HF patients. Clinical Trial Registration: COMPARE - www.ClinicalTrials.gov; IMPEL - www.ClinicalTrials.gov; Heart Failure at Home - www.ClinicalTrials.gov, identifier: NCT02939053; NCT02857231; NCT04013373.

Keywords: bioimpedance spectroscopy; case study; extracellular fluid; heart failure; total body water.

Conflict of interest statement

AA, AD-B, and JH provide consultancy services to ImpediMed. BM and RG are employees of ImpediMed. As funder of this clinical research, ImpediMed provided no-cost access to bioimpedance spectroscopy devices for use in accordance with clinical trial protocols. ImpediMed also provided funding for clinical trial-related costs and third-party data management and biostatistical support.

Copyright © 2021 Accardi, Matsubara, Gaw, Daleiden-Burns and Heywood.

Figures

Figure 1
Figure 1
SOZO device. As shown, the device is configured to perform bioimpedance spectroscopy (BIS) measurements with the subject in a standing position. Bare hands and feet must be in direct contact with the electrodes (i.e., no shoes, socks, stockings, or gloves), and metallic/electronic items should be removed. BIS measurement and fluid status reporting takes ~30 s.
Figure 2
Figure 2
Extracellular fluid percentage of total body water; histogram (A), cumulative frequency curves (B). Extracellular fluid percentage of total body water (ECF%TBW) for Healthy Control Subjects (CON-pop, N = 69, shown in gray) and Heart Failure Patients (HF-pop, N = 64, shown in blue); histogram (A), and cumulative frequency curves (B).
Figure 3
Figure 3
Extracellular fluid percentage of total body water; box-and-whisker plots (A), and clinical strata (B). (A) box-and-whisker plots for bioimpedance spectroscopy-derived extracellular fluid percentage of total body water (ECF%TBW) for Healthy Control Subjects (CON-pop, gray plot) and Heart Failure Patients (HF-pop, blue plot). (B) Normal, bottom three CON-pop quartiles; Elevated, bound by CON-pop 3rd quartile and HF-pop 3rd quartile; Fluid Overload, highest HF-pop quartile.
Figure 4
Figure 4
Lower extremity R0 impedance measurements vs. inferior vena cava (IVC) size; left leg (A), right leg (B). Left leg (A) and right leg (B) scatter plots for R0 impedance vs. inferior vena cava (IVC) size for the subgroup of 12 heart failure patients enrolled in the IMPEL clinical study (ClinicalTrials.gov identifier NCT02857231). Right atrial pressure (RAP) categories: RAP1 in gray (<8 mmHg), RAP2 in orange (8–14.99 mmHg), and in blue RAP3 (15 mmHg). R0 impedance is inversely related to extracellular fluid volume. Hence, in both legs, lower impedance values are associated with larger IVC size and higher right atrial pressures. R0, resistance at zero Hertz; IVC, inferior vena cava; RAP, right atrial pressure; cm, centimeter.
Figure 5
Figure 5
Case Study: 87 year-old man with two heart failure readmissions. ECF, extracellular fluid; ICF, intracellular fluid; TBW, total body water; ECF%TBW, extracellular fluid as a percentage of total body water; mg, milligram; po, oral; qd, daily; L, liters; kg, kilograms; BIS, bioimpedance spectroscopy; SNF, skilled nursing facility. The red line at 51% ECF%TBW indicates the transition from elevated fluid volume to fluid overload.

References

    1. Savarese G, Lund LH. Global public health burden of heart failure. Cardiac Failure Rev. (2017) 3:7–11. 10.15420/cfr.2016:25:2
    1. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. . Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. (2019) 139:e56–528. 10.1161/CIR.0000000000000659
    1. Anand I. Stable but progressive nature of heart failure: considerations for primary care physicians. Am J Cardiovasc Drugs. (2018) 18:333–45. 10.1007/s40256-018-0277-0
    1. Dharmarajan K, Hsieh AF, Lin Z, Bueno H, Ross JS, Horwitz LI, et al. . Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. Jama. (2013) 309:355–63. 10.1001/jama.2012.216476
    1. Desai AS, Stevenson LW. Rehospitalization for heart failure: predict or prevent? Circulation. (2012) 126:501–6. 10.1161/CIRCULATIONAHA.112.125435
    1. Cornish B. Bioimpedance analysis: scientific background. Lymphat Res Biol. (2006) 4:47–50. 10.1089/lrb.2006.4.47
    1. Ward L. Inter-instrument comparison of bioimpedance spectroscopic analysers. Open Med Devices J. (2009) 1:3–10. 10.2174/1875181400901010003
    1. Beckmann L, Cordes A, Saygili E, Schmeink A, Schauerte P, Walter M, et al. . Monitoring of body fluid in patients with chronic heart failure using Bioimpedance-Spectroscopy. IFMBE Proc 25/VII. (2009) 25:532–5. 10.1007/978-3-642-03885-3_148
    1. Weyer S, Zink MD, Wartzek T, Leicht L, Mischke K, Vollmer T, et al. . Bioelectrical impedance spectroscopy as a fluid management system in heart failure. Physiol Meas. (2014) 35:917–30. 10.1088/0967-3334/35/6/917
    1. Zink MD, Weyer S, Pauly K, Napp A, Dreher M, Leonhardt S, et al. . Feasibility of bioelectrical impedance spectroscopy measurement before and after thoracentesis. BioMed Res Int. (2015) 2015:810797. 10.1155/2015/810797
    1. Skrabal F, Pichler GP, Gratze G, Holler A. Adding “hemodynamic and fluid leads” to the ECG. Part I: the electrical estimation of BNP, chronic heart failure (CHF) and extracellular fluid (ECF) accumulation. Med Eng Phys. (2014) 36:896–904. 10.1016/j.medengphy.2014.03.015
    1. Ribas N, Nescolarde L, MDomingo M, Gastelurrutia P, Bayes-Genis A, Rosell-Ferrer J. Longitudinal and transversal bioimpedance measurements in addition to diagnosis of heart failure. J Phys Conference Ser. (2010) 224:12099. 10.1088/1742-6596/224/1/012099
    1. Birzniece V, Khaw CH, Nelson AE, Meinhardt U, Ho KK. A critical evaluation of bioimpedance spectroscopy analysis in estimating body composition during GH treatment: comparison with bromide dilution and dual X-ray absorptiometry. Eur J Endocrinol. (2015) 172:21–8. 10.1530/EJE-14-0660
    1. van den Ham EC, Kooman JP, Christiaans MH, Nieman FH, Van Kreel BK, Heidendal GA, et al. . Body composition in renal transplant patients: bioimpedance analysis compared to isotope dilution, dual energy X-ray absorptiometry, and anthropometry. J Am Soc Nephrol. (1999) 10:1067–79.
    1. Cicone Z, Holmes C, Hornikel B, Freeborn T, Moon J, Fedewa M, et al. . Agreement between deuterium oxide and bioimpedance spectroscopy measures of total body water: 570 May 29 1:15 PM - 1:30 PM. Med Sci Sports Exerc. (2019) 51:147. 10.1249/01.mss.0000560945.81327.b6
    1. Kerr A, Slater G, Byrne N, Chaseling J. Validation of bioelectrical impedance spectroscopy to measure total body water in resistance-trained males. Int J Sport Nutr Exerc Metabol. (2015) 25:494–503. 10.1123/ijsnem.2014-0188
    1. Moon JR, Smith AE, Tobkin SE, Lockwood CM, Kendall KL, Graef JL, et al. . Total body water changes after an exercise intervention tracked using bioimpedance spectroscopy: a deuterium oxide comparison. Clin Nutr. (2009) 28:516–25. 10.1016/j.clnu.2009.04.025
    1. Moon JR, Tobkin SE, Roberts MD, Dalbo VJ, Kerksick CM, Bemben MG, et al. . Total body water estimations in healthy men and women using bioimpedance spectroscopy: a deuterium oxide comparison. Nutr Metab. (2008) 5:7. 10.1186/1743-7075-5-7
    1. Accardi AJ, Burns A, Heywood JT. Correlation of limb bioimpedance to echocardiographic indicators of congestion in patients with NYHA class II/III heart failure. Cardiol Vasc Res. (2019) 3:1–5. 10.33425/2639-8486.1039
    1. Ward LC, Dylke E, Czerniec S, Isenring E, Kilbreath SL. Confirmation of the reference impedance ratios used for assessment of breast cancer-related lymphedema by bioelectrical impedance spectroscopy. Lymphat Res Biol. (2011) 9:47–51. 10.1089/lrb.2010.0014
    1. Ward LC, Dylke E, Czerniec S, Isenring E, Kilbreath SL. Reference ranges for assessment of unilateral lymphedema in legs by bioelectrical impedance spectroscopy. Lymphat Res Biol. (2011) 9:43–6. 10.1089/lrb.2010.0024
    1. Cornish BH, Chapman M. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology. (2001) 34:2–11.
    1. Ward L. Is BIS ready for prime time as the gold standard measure? J Lymphoedema. (2009) 4:52–6. Available online at:
    1. Suehiro K, Morikage N, Yamashita O, Harada T, Ueda K, Samura M, et al. . Distribution of extracellular fluid in legs with venous edema and lymphedema. Lymphat Res Biol. (2016) 14:156–61. 10.1089/lrb.2016.0004
    1. Chamney PW, Kramer M, Rode C, Kleinekofort W, Wizemann V. A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance. Kidney Int. (2002) 61:2250–8. 10.1046/j.1523-1755.2002.00377.x
    1. Marcelli D, Wabel P, Wieskotten S, Ciotola A, Grassmann A, Di Benedetto A, et al. . Physical methods for evaluating the nutrition status of hemodialysis patients. J Nephrol. (2015) 28:523–30. 10.1007/s40620-015-0189-x
    1. Higgins KJ, Reid PM, Going SB, Howell WH. Validation of bioimpedance spectroscopy to assess acute changes in hydration status. Med Sci Sports Exerc. (2007) 39:984–90. 10.1249/mss.0b013e31803bb4d4
    1. Grimnes S, Martinsen OG. Bioimpedance and Bioelectricity Basics. 3rd ed. Cambridge, MA: Academic Press; (2014). 10.1016/B978-0-12-411470-8.00011-8
    1. Vetter TR. Fundamentals of research data and variables: the devil is in the details. Anesth Analg. (2017) 125:1375–80. 10.1213/ANE.0000000000002370
    1. Brahmbhatt DH, Cowie MR. Remote management of heart failure: an overview of telemonitoring technologies. Cardiac Failure Rev. (2019) 5:86–92. 10.15420/cfr.2019.5.3
    1. Piek A, Du W, de Boer RA, Silljé HHW. Novel heart failure biomarkers: why do we fail to exploit their potential? Crit Rev Clin Lab Sci. (2018) 55:246–63. 10.1080/10408363.2018.1460576
    1. Desai AS. Home monitoring heart failure care does not improve patient outcomes: looking beyond telephone-based disease management. Circulation. (2012) 125:828–36. 10.1161/CIRCULATIONAHA.111.031179
    1. Costanzo MR, Stevenson LW, Adamson PB, Desai AS, Heywood JT, Bourge RC, et al. . Interventions linked to decreased heart failure hospitalizations during ambulatory pulmonary artery pressure monitoring. JACC Heart Failure. (2016) 4:333–44. 10.1016/j.jchf.2015.11.011
    1. Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, et al. . Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. (2011) 377:658–66. 10.1016/S0140-6736(11)60101-3
    1. Sandhu AT, Goldhaber-Fiebert JD, Owens DK, Turakhia MP, Kaiser DW, Heidenreich PA. Cost-effectiveness of implantable pulmonary artery pressure monitoring in chronic heart failure. JACC Heart Failure. (2016) 4:368–75. 10.1016/j.jchf.2015.12.015
    1. Zile MR, Bennett TD, St John Sutton M, Cho YK, Adamson PB, Aaron MF, et al. . Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation. (2008) 118:1433–41. 10.1161/CIRCULATIONAHA.108.783910
    1. Stevenson LW, Zile M, Bennett TD, Kueffer FJ, Jessup ML, Adamson P, et al. . Chronic ambulatory intracardiac pressures and future heart failure events. Circulation Heart Failure. (2010) 3:580–7. 10.1161/CIRCHEARTFAILURE.109.923300
    1. Kobayashi M, Girerd N, Duarte K, Chouihed T, Chikamori T, Pitt B, et al. . Estimated plasma volume status in heart failure: clinical implications and future directions. Clin Res Cardiol. (2021). 10.1007/s00392-020-01794-8. [Epub ahead of print].
    1. Mottola C, Girerd N, Coiro S, Lamiral Z, Rossignol P, Frimat L, et al. . Evaluation of subclinical fluid overload using lung ultrasound and estimated plasma volume in the postoperative period following kidney transplantation. Transplant Proc. (2018) 50:1336–41. 10.1016/j.transproceed.2018.03.007
    1. Horton CF, Collins SP. The role of the emergency department in the patient with acute heart failure. Curr Cardiol Rep. (2013) 15:365. 10.1007/s11886-013-0365-3
    1. CDC . National Health and Nutrition Examination Survey III (NHANES III) 1988–1994 [Body Composition Normal Ranges, Stratified by Age and Gender]. Available online at: (accessed October 25, 2017).
    1. Sergi G, Lupoli L, Volpato S, Bertani R, Coin A, Perissinotto E, et al. . Body fluid distribution in elderly subjects with congestive heart failure. Ann Clin Lab Sci. (2004) 34:416–22.
    1. Liu MH, Wang CH, Huang YY, Tung TH, Lee CM, Yang NI, et al. . Edema index established by a segmental multifrequency bioelectrical impedance analysis provides prognostic value in acute heart failure. J Cardiovasc Med. (2012) 13:299–306. 10.2459/JCM.0b013e328351677f
    1. Cornish BH, Ward LC, Thomas BJ, Jebb SA, Elia M. Evaluation of multiple frequency bioelectrical impedance and Cole-Cole analysis for the assessment of body water volumes in healthy humans. Eur J Clin Nutr. (1996) 50:159–64.
    1. Earthman C, Traughber D, Dobratz J, Howell W. Bioimpedance spectroscopy for clinical assessment of fluid distribution and body cell mass. Nutr Clin Practice. (2007) 22:389–405. 10.1177/0115426507022004389
    1. Park CS, Lee SE, Cho HJ, Kim YJ, Kang HJ, Oh BH, et al. . Body fluid status assessment by bio-impedance analysis in patients presenting to the emergency department with dyspnea. Korean J Internal Med. (2018) 33:911–21. 10.3904/kjim.2016.358
    1. Zink MD, König F, Weyer S, Willmes K, Leonhardt S, Marx N, et al. . Segmental bioelectrical impedance spectroscopy to monitor fluid status in heart failure. Sci Rep. (2020) 10:3577. 10.1038/s41598-020-60358-y
    1. Lindholm D, Fukaya E, Leeper NJ, Ingelsson E. Bioimpedance and new-onset heart failure: a longitudinal study of >500,000 individuals from the general population. J Am Heart Assoc. (2018) 7:8970. 10.1161/JAHA.118.008970

Source: PubMed

3
Suscribir